Although doses of DPP-4 inhibitors that reduce enzyme activity in the intestinal lumen without prominent systemic effects (gut-selective) improve glucose tolerance and increase both GLP-1 and GIP, they are not as potent as doses that decrease plasma DPP-4 activity as well [19, 20]
Two-peptide research blend (BPC-157 + TB-500) in a single vial
The highest-dose group lost 8.96 kg placebo-adjusted over 12 weeks [4]
Our expert provider will evaluate your individual needs and health goals to recommend the best treatment option for you
Hofbauer LC, Witvrouw R, Varga Z, Shiota N, Cremer M, Tanko LB, et al
Understanding the full landscape is what allows a clinician to place MIC injections honestly